540395 Stock Overview
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Chemcrux Enterprises Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹264.95 |
52 Week High | ₹380.95 |
52 Week Low | ₹246.10 |
Beta | 0.54 |
1 Month Change | -0.17% |
3 Month Change | -7.84% |
1 Year Change | -25.12% |
3 Year Change | 311.84% |
5 Year Change | 813.62% |
Change since IPO | 3,579.86% |
Recent News & Updates
Recent updates
Shareholder Returns
540395 | IN Chemicals | IN Market | |
---|---|---|---|
7D | -4.1% | -2.5% | -2.5% |
1Y | -25.1% | 17.2% | 44.5% |
Return vs Industry: 540395 underperformed the Indian Chemicals industry which returned 17.2% over the past year.
Return vs Market: 540395 underperformed the Indian Market which returned 44.5% over the past year.
Price Volatility
540395 volatility | |
---|---|
540395 Average Weekly Movement | 4.7% |
Chemicals Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 540395 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540395's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 94 | Sanjaybhai Marathe | www.chemcrux.com |
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. The company’s chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, dichloro benzoic acid, 4-chloro benzoic acid -3-sulfonamide, 4 chloro 3 nitro benzoic acid, 2 chloro 5 nitro benzoic acid, meta nitro benzoic acid, aceturic acid, and lassamide acid.
Chemcrux Enterprises Limited Fundamentals Summary
540395 fundamental statistics | |
---|---|
Market cap | ₹3.95b |
Earnings (TTM) | ₹94.68m |
Revenue (TTM) | ₹799.35m |
41.4x
P/E Ratio4.9x
P/S RatioIs 540395 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
540395 income statement (TTM) | |
---|---|
Revenue | ₹799.35m |
Cost of Revenue | ₹352.14m |
Gross Profit | ₹447.21m |
Other Expenses | ₹352.53m |
Earnings | ₹94.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 6.39 |
Gross Margin | 55.95% |
Net Profit Margin | 11.84% |
Debt/Equity Ratio | 35.4% |
How did 540395 perform over the long term?
See historical performance and comparison